CK-MB Test: Normal Ranges, High Levels & Heart Attack Diagnosis

Q: Why has troponin replaced CK-MB as the primary cardiac biomarker?

Cardiac troponins (cTnI and cTnT) are more sensitive and more specific for myocardial injury than CK-MB. Troponin is detectable earlier with high-sensitivity assays, remains elevated longer (up to 2 weeks), and is not significantly elevated by skeletal muscle injury. CK-MB retains value for detecting reinfarction and timing of injury due to its faster normalization (48–72 hours vs. 1–2 weeks for troponin).

Q: What is the CK-MB relative index?

The CK-MB relative index is calculated as (CK-MB / total CK) × 100. A ratio >5% suggests that the CK-MB elevation is primarily from cardiac muscle rather than skeletal muscle. This is helpful when both total CK and CK-MB are elevated, as occurs in rhabdomyolysis with concurrent cardiac injury.

CK-MB

Cardiac

What is CK-MB?

CK-MB (creatine kinase-MB isoenzyme) is one of three isoenzymes of creatine kinase (CK), an enzyme that catalyzes the reversible transfer of phosphate from creatine phosphate to ADP, generating ATP for cellular energy. The three CK isoenzymes differ in their tissue distribution: CK-MM predominates in skeletal muscle, CK-BB in brain and smooth muscle, and CK-MB in cardiac muscle (comprising approximately 20–30% of total cardiac CK, compared to 1–3% of skeletal muscle CK). Because of its relative cardiac specificity, CK-MB was historically the gold-standard biomarker for diagnosing acute myocardial infarction (AMI).

While high-sensitivity cardiac troponins (hs-cTnI and hs-cTnT) have largely replaced CK-MB as the preferred biomarker for AMI diagnosis due to their superior sensitivity and specificity, CK-MB retains important clinical roles. Its faster rise-and-fall kinetics (rises within 3–6 hours, peaks at 12–24 hours, and normalizes within 48–72 hours) make it useful for detecting reinfarction in the early post-MI period, when troponin levels may still be elevated from the index event. CK-MB is also used to assess infarct size and timing, evaluate periprocedural myocardial injury after PCI or CABG, and in some settings where troponin assays are unavailable.

Why It Matters

CK-MB was the cornerstone of myocardial infarction diagnosis for decades and remains clinically relevant in specific scenarios. Its faster clearance compared to troponin makes it particularly useful for detecting reinfarction—a second rise in CK-MB after initial normalization is a reliable indicator of a new myocardial injury event when troponin levels remain elevated from the first event. CK-MB mass (measured by immunoassay) has largely replaced CK-MB activity for better sensitivity. The CK-MB relative index (CK-MB/total CK × 100) helps distinguish cardiac from skeletal muscle CK-MB release: a ratio >5% suggests myocardial origin.

Normal Reference Ranges

Group	Range	Unit
Adults (CK-MB mass)	0–5	ng/mL
CK-MB relative index	<5%	(CK-MB/total CK × 100)

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High CK-MB Levels Mean

Common Causes

Acute myocardial infarction
Myocarditis
Cardiac surgery (CABG, valve surgery)
Percutaneous coronary intervention (periprocedural injury)
Cardiac contusion (blunt chest trauma)
Severe skeletal muscle injury or rhabdomyolysis (CK-MB from skeletal muscle)
Muscular dystrophies (chronic skeletal muscle disease)
Strenuous exercise (particularly endurance athletes)
Electrical cardioversion or defibrillation

Possible Symptoms

Chest pain or pressure
Shortness of breath
Diaphoresis (sweating)
Nausea
Pain radiating to arm, jaw, or back
Dizziness or lightheadedness
Palpitations

What to do: Elevated CK-MB in the setting of chest pain and ECG changes requires urgent cardiology evaluation for acute myocardial infarction. Obtain serial measurements (0, 3–6, and 12 hours) to document the rise-and-fall pattern characteristic of MI. Concurrently measure troponin, which is the preferred primary biomarker. Calculate the CK-MB relative index to distinguish cardiac from skeletal muscle sources. If CK-MB is elevated without troponin elevation, consider skeletal muscle injury. In post-MI patients, a secondary rise in CK-MB after initial normalization suggests reinfarction and requires immediate reevaluation.

What Low CK-MB Levels Mean

Common Causes

Normal result—no myocardial injury detected
Low muscle mass

Possible Symptoms

No symptoms associated with low CK-MB

What to do: Low or undetectable CK-MB is normal and expected. In the evaluation of chest pain, CK-MB should not be used as the sole biomarker—high-sensitivity cardiac troponin is the preferred test. A normal CK-MB within the first 6 hours of symptom onset does not exclude MI, and serial measurements or troponin should be used.

When Is CK-MB Testing Recommended?

Suspected acute myocardial infarction (alongside troponin)
Detecting reinfarction when troponin is still elevated from initial event
Evaluating periprocedural myocardial injury after PCI or CABG
Assessment of myocardial infarct size and timing
When high-sensitivity troponin assays are unavailable

Frequently Asked Questions

Cardiac troponins (cTnI and cTnT) are more sensitive and more specific for myocardial injury than CK-MB. Troponin is detectable earlier with high-sensitivity assays, remains elevated longer (up to 2 weeks), and is not significantly elevated by skeletal muscle injury. CK-MB retains value for detecting reinfarction and timing of injury due to its faster normalization (48–72 hours vs. 1–2 weeks for troponin).

The CK-MB relative index is calculated as (CK-MB / total CK) × 100. A ratio >5% suggests that the CK-MB elevation is primarily from cardiac muscle rather than skeletal muscle. This is helpful when both total CK and CK-MB are elevated, as occurs in rhabdomyolysis with concurrent cardiac injury.

Yes. Intense or prolonged exercise, particularly marathon running and other endurance sports, can elevate CK-MB from skeletal muscle. Skeletal muscle contains small amounts (1–3%) of CK-MB, and massive muscle breakdown can produce significant CK-MB elevations. In exercise-related elevations, the CK-MB relative index is typically <5%, helping distinguish it from cardiac injury.

Related Biomarkers

BNPB-Type Natriuretic Peptide / NT-proBNP LDHLactate Dehydrogenase

Want your CK-MB levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.